A citation-based method for searching scientific literature

Georgia Tsaouli, Elisabetta Ferretti, Diana Bellavia, Alessandra Vacca, Maria Pia Felli. J Immunol Res 2019
Times Cited: 10







List of co-cited articles
39 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Notch signalling: sensor and instructor of the microenvironment to coordinate cell fate and organ morphogenesis.
Bethan Lloyd-Lewis, Philippos Mourikis, Silvia Fre. Curr Opin Cell Biol 2019
25
10

TP53 mutants in the tower of babel of cancer progression.
Alessandra Bisio, Yari Ciribilli, Gilberto Fronza, Alberto Inga, Paola Monti. Hum Mutat 2014
29
10

Screening of colorectal cancer: present and future.
Marcello Maida, Fabio Salvatore Macaluso, Gianluca Ianiro, Francesca Mangiola, Emanuele Sinagra, Georgina Hold, Carlo Maida, Giovanni Cammarota, Antonio Gasbarrini, Giuseppe Scarpulla. Expert Rev Anticancer Ther 2017
72
10

Immunotherapy in Colorectal Cancer.
Mehmet Sitki Copur. Oncology (Williston Park) 2019
5
20

Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers.
Hao-Xiang Wu, Yan-Xing Chen, Zi-Xian Wang, Qi Zhao, Ming-Ming He, Ying-Nan Wang, Feng Wang, Rui-Hua Xu. J Immunother Cancer 2019
43
10

Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations.
Daniel Sanghoon Shin, Jesse M Zaretsky, Helena Escuin-Ordinas, Angel Garcia-Diaz, Siwen Hu-Lieskovan, Anusha Kalbasi, Catherine S Grasso, Willy Hugo, Salemiz Sandoval, Davis Y Torrejon,[...]. Cancer Discov 2017
699
10

MHC-II neoantigens shape tumour immunity and response to immunotherapy.
Elise Alspach, Danielle M Lussier, Alexander P Miceli, Ilya Kizhvatov, Michel DuPage, Adrienne M Luoma, Wei Meng, Cheryl F Lichti, Ekaterina Esaulova, Anthony N Vomund,[...]. Nature 2019
306
10

CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
Ryuma Tokunaga, Wu Zhang, Madiha Naseem, Alberto Puccini, Martin D Berger, Shivani Soni, Michelle McSkane, Hideo Baba, Heinz-Josef Lenz. Cancer Treat Rev 2018
457
10

Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers: A Systematic Review and Meta-analysis.
Christopher J D Wallis, Mohit Butaney, Raj Satkunasivam, Stephen J Freedland, Sandip P Patel, Omid Hamid, Sumanta K Pal, Zachary Klaassen. JAMA Oncol 2019
121
10

Wnt signalling in stem cells and cancer.
Tannishtha Reya, Hans Clevers. Nature 2005
10


Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden.
Zachary R Chalmers, Caitlin F Connelly, David Fabrizio, Laurie Gay, Siraj M Ali, Riley Ennis, Alexa Schrock, Brittany Campbell, Adam Shlien, Juliann Chmielecki,[...]. Genome Med 2017
10

Complex heatmaps reveal patterns and correlations in multidimensional genomic data.
Zuguang Gu, Roland Eils, Matthias Schlesner. Bioinformatics 2016
10

Mechanisms of resistance to immune checkpoint inhibitors.
Russell W Jenkins, David A Barbie, Keith T Flaherty. Br J Cancer 2018
598
10

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.
Antonio Colaprico, Tiago C Silva, Catharina Olsen, Luciano Garofano, Claudia Cava, Davide Garolini, Thais S Sabedot, Tathiane M Malta, Stefano M Pagnotta, Isabella Castiglioni,[...]. Nucleic Acids Res 2016
10


Chemical Modulation of WNT Signaling in Cancer.
Li-Shu Zhang, Lawrence Lum. Prog Mol Biol Transl Sci 2018
12
10

High Membranous Expression of Fatty Acid Transport Protein 4 Is Associated with Tumorigenesis and Tumor Progression in Clear Cell Renal Cell Carcinoma.
Young-Sik Kim, Jiyoon Jung, Hoiseon Jeong, Ju-Han Lee, Hwa Eun Oh, Eung Seok Lee, Jung-Woo Choi. Dis Markers 2019
22
10



Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types.
Feng Wang, Qi Zhao, Ying-Nan Wang, Ying Jin, Ming-Ming He, Ze-Xian Liu, Rui-Hua Xu. JAMA Oncol 2019
165
10

Colorectal cancer screening: An updated review of the available options.
Iyad A Issa, Malak Noureddine. World J Gastroenterol 2017
240
10

Wnt/beta-catenin signaling: components, mechanisms, and diseases.
Bryan T MacDonald, Keiko Tamai, Xi He. Dev Cell 2009
10

Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer.
Tarrik M Zaid, Tsz-Lun Yeung, Melissa S Thompson, Cecilia S Leung, Tom Harding, Ngai-Na Co, Rosie S Schmandt, Suet-Ying Kwan, Cristian Rodriguez-Aguay, Gabriel Lopez-Berestein,[...]. Clin Cancer Res 2013
63
10

Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
Xi Ai, Yanhui Wu, Wei Zhang, Zhanguo Zhang, Guannan Jin, Jianping Zhao, Jingjing Yu, Youzhi Lin, Wanguang Zhang, Huifang Liang,[...]. Cancer Biol Ther 2013
17
10

Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate.
Shumei Kato, Aaron Goodman, Vighnesh Walavalkar, Donald A Barkauskas, Andrew Sharabi, Razelle Kurzrock. Clin Cancer Res 2017
551
10

The Immune Landscape of Cancer.
Vésteinn Thorsson, David L Gibbs, Scott D Brown, Denise Wolf, Dante S Bortone, Tai-Hsien Ou Yang, Eduard Porta-Pardo, Galen F Gao, Christopher L Plaisier, James A Eddy,[...]. Immunity 2018
10


Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
Aravind Subramanian, Pablo Tamayo, Vamsi K Mootha, Sayan Mukherjee, Benjamin L Ebert, Michael A Gillette, Amanda Paulovich, Scott L Pomeroy, Todd R Golub, Eric S Lander,[...]. Proc Natl Acad Sci U S A 2005
10


Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.
Curtis H Kugel, Stephen M Douglass, Marie R Webster, Amanpreet Kaur, Qin Liu, Xiangfan Yin, Sarah A Weiss, Farbod Darvishian, Rami N Al-Rohil, Abibatou Ndoye,[...]. Clin Cancer Res 2018
151
10

The emerging role of immunotherapy in colorectal cancer.
David Lynch, Adrian Murphy. Ann Transl Med 2016
50
10

Inhibition of ERK1/2 in cancer-associated pancreatic stellate cells suppresses cancer-stromal interaction and metastasis.
Zilong Yan, Kenoki Ohuchida, Shuang Fei, Biao Zheng, Weiyu Guan, Haimin Feng, Shin Kibe, Yohei Ando, Kazuhiro Koikawa, Toshiya Abe,[...]. J Exp Clin Cancer Res 2019
36
10

Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers.
Min Yuen Teo, Kenneth Seier, Irina Ostrovnaya, Ashley M Regazzi, Brooke E Kania, Meredith M Moran, Catharine K Cipolla, Mark J Bluth, Joshua Chaim, Hikmat Al-Ahmadie,[...]. J Clin Oncol 2018
293
10

Implication of MAPK1/MAPK3 signalling pathway in t(8;9)(p22;24)/PCM1-JAK2 myelodysplastic/myeloproliferative neoplasms.
Elena Masselli, Cristina Mecucci, Giuliana Gobbi, Cecilia Carubbi, Valentina Pierini, Gabriella Sammarelli, Sabrina Bonomini, Lucia Prezioso, Elena Rossetti, Cecilia Caramatti,[...]. Br J Haematol 2013
8
12

Robust enumeration of cell subsets from tissue expression profiles.
Aaron M Newman, Chih Long Liu, Michael R Green, Andrew J Gentles, Weiguo Feng, Yue Xu, Chuong D Hoang, Maximilian Diehn, Ash A Alizadeh. Nat Methods 2015
10

FGFR4 promotes stroma-induced epithelial-to-mesenchymal transition in colorectal cancer.
Rui Liu, Jingyi Li, Ke Xie, Tao Zhang, Yunlong Lei, Yi Chen, Lu Zhang, Kai Huang, Kui Wang, Hong Wu,[...]. Cancer Res 2013
74
10

Ovarian Cancer-Why Lipids Matter.
Guangyuan Zhao, Horacio Cardenas, Daniela Matei. Cancers (Basel) 2019
26
10

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
10

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective.
Yan Xu, Shumei Song, Zhenning Wang, Jaffer A Ajani. Cell Commun Signal 2019
20
10

CREBBP and p300 lysine acetyl transferases in the DNA damage response.
Ilaria Dutto, Claudia Scalera, Ennio Prosperi. Cell Mol Life Sci 2018
50
10

Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.
Michael J Overman, Ray McDermott, Joseph L Leach, Sara Lonardi, Heinz-Josef Lenz, Michael A Morse, Jayesh Desai, Andrew Hill, Michael Axelson, Rebecca A Moss,[...]. Lancet Oncol 2017
10

SPEN protein expression and interactions with chromatin in mouse testicular cells.
Joanna Korfanty, Tomasz Stokowy, Marek Chadalski, Agnieszka Toma-Jonik, Natalia Vydra, Piotr Widłak, Bartosz Wojtaś, Bartłomiej Gielniewski, Wieslawa Widlak. Reproduction 2018
3
33

Impact of oncogenic pathways on evasion of antitumour immune responses.
Stefani Spranger, Thomas F Gajewski. Nat Rev Cancer 2018
327
10


Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis.
Fabio Conforti, Laura Pala, Vincenzo Bagnardi, Tommaso De Pas, Marco Martinetti, Giuseppe Viale, Richard D Gelber, Aron Goldhirsch. Lancet Oncol 2018
407
10

The potential of targeting Wnt/β-catenin in colon cancer.
Ana Sebio, Michael Kahn, Heinz-Josef Lenz. Expert Opin Ther Targets 2014
147
10


Notch3 Targeting: A Novel Weapon against Ovarian Cancer Stem Cells.
Simona Ceccarelli, Francesca Megiorni, Diana Bellavia, Cinzia Marchese, Isabella Screpanti, Saula Checquolo. Stem Cells Int 2019
18
10

Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype.
M V Giuli, E Giuliani, I Screpanti, D Bellavia, S Checquolo. J Oncol 2019
64
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.